E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation

Molecular Cell

Volumn 17, Issue 2, 2005, Pages 251-264

  Thomas, Mary C ^a   Chiang, Cheng Ming ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; PROTEIN E6; PROTEIN P300; PROTEIN P53;

ACETYLATION; ARTICLE; CHROMATIN; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; GENE TARGETING; NONHUMAN; NUCLEOSOME; PROTEIN DEGRADATION; PROTEIN INDUCTION; ULTRAVIOLET IRRADIATION;

ACETYL COENZYME A; ACETYLATION; ACETYLTRANSFERASES; AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE PROTEINS; CELLS, CULTURED; CHROMATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; E1A-ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASES; HISTONES; HUMANS; MACROMOLECULAR SUBSTANCES; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PROTEASOME ENDOPEPTIDASE COMPLEX; REPRESSOR PROTEINS; SEQUENCE ALIGNMENT; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 12344295621     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2004.12.016     Document Type: Article

References (62)

1. Avantaggiati M.L., Ogryzko V., Gardner K., Giordano A., Levine A.S., Kelly K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell. 89:1997;1175-1184
2. Barlev N.A., Emelyanov A.V., Castagnino P., Zegerman P., Bannister A.J., Sepulveda M.A., Robert F., Tora L., Kouzarides T., Birshtein B.K., Berger S.L. A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription. Mol. Cell. Biol. 23:2003;6944-6957
3. Boube M., Joulia L., Cribbs D.L., Bourbon H.-M. Evidence for a mediator of RNA polymerase II transcriptional regulation conserved from yeast to man. Cell. 110:2002;143-151
4. Burke L.J., Baniahmad A. Co-repressors 2000. FASEB J. 14:2000;1876-1888
5. Burley S.K., Roeder R.G. TATA box mimicry by TFIID. autoinhibition of Pol II transcription Cell. 94:1998;551-553
6. Chenna R., Sugawara H., Koike T., Lopez R., Gibson T.J., Higgins D.G., Thompson J.D. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31:2003;3497-3500
7. Chiang C.-M., Roeder R.G. Expression and purification of general transcription factors by FLAG epitope-tagging and peptide elution. Pept. Res. 6:1993;62-64
8. Ciechanover A. The ubiquitin-proteasome pathway. on protein death and cell life EMBO J. 17:1998;7151-7160
9. Crook T., Tidy J.A., Vousden K.H. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell. 67:1991;547-556
10. Deckert J., Struhl K. Targeted recruitment of Rpd3 histone deacetylase represses transcription by inhibiting recruitment of Swi/Snf, SAGA, and TATA binding protein. Mol. Cell. Biol. 22:2002;6458-6470
11. Dial R., Sun Z.Y., Freedman S.J. Three conformational states of the p300 CH1 domain define its functional properties. Biochemistry. 42:2003;9937-9945
12. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825
13. Fischle W., Wang Y., Allis C.D. Histones and chromatin cross-talk. Curr. Opin. Cell Biol. 15:2003;172-183
14. Foster S.A., Demers G.W., Etscheid B.G., Galloway D.A. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J. Virol. 68:1994;5698-5705
15. Georges S.A., Giebler H.A., Cole P.A., Luger K., Laybourn P.J., Nyborg J.K. Tax recruitment of CBP/p300, via the KIX domain, reveals a potent requirement for acetyltransferase activity that is chromatin dependent and histone tail independent. Mol. Cell. Biol. 23:2003;3392-3404
16. Girdwood D., Bumpass D., Vaughan O.A., Thain A., Anderson L.A., Snowden A.W., Garcia-Wilson E., Perkins N.D., Hay R.T. p300 transcriptional repression is mediated by SUMO modification. Mol. Cell. 11:2003;1043-1054
17. Hamiche A., Sandaltzopoulos R., Gdula D.A., Wu C. ATP-dependent histone octamer sliding mediated by the chromatin remodeling complex NURF. Cell. 97:1999;833-842
18. Harton J.A., Zika E., Ting J.P. The histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivator. J. Biol. Chem. 276:2001;38715-38720
19. Hou S.Y., Wu S.-Y., Zhou T., Thomas M.C., Chiang C.-M. Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA Polymerase II-TFIIF preinitiation complex. Mol. Cell. Biol. 20:2000;113-125
20. Huibregtse J.M., Scheffner M., Howley P.M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10:1991;4129-4135
21. Inga A., Storici F., Darden T.A., Resnick M.A. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol. Cell. Biol. 22:2002;8612-8625
22. Ito T., Levenstein M.E., Fyodorov D.V., Kutach A.K., Kobayashi R., Kadonaga J.T. ACF consists of two subunits, Acf1 and ISWI, that function cooperatively in the ATP-dependent catalysis of chromatin assembly. Genes Dev. 13:1999;1529-1539
23. Jiang Y.-H., Armstrong D., Albrecht U., Atkins C.M., Noebels J.L., Eichele G., Sweatt J.D., Beaudet A.L. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 21:1998;799-811
24. Kahyo T., Nishida T., Yasuda H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell. 8:2001;713-718
25. Kanno T., Kanno Y., Siegel R.M., Jang M.K., Lenardo M.J., Ozato K. Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Mol. Cell. 13:2004;33-43
26. Kazemi S., Papadopoulou S., Li S., Su Q., Wang S., Yoshimura A., Matlashewski G., Dever T.E., Koromilas A.E. Control of α subunit of eukaryotic translation initiation factor 2 (eIF2α) phosphorylation by the human papillomavirus type 18 E6 oncoprotein. implications for eIF2α-dependent gene expression and cell death Mol. Cell. Biol. 24:2004;3415-3429
27. Koop R., Di Croce L., Beato M. Histone H1 enhances synergistic activation of the MMTV promoter in chromatin. EMBO J. 22:2003;588-599
28. Korenjak M., Taylor-Harding B., Binné U.K., Satterlee J.S., Stevaux O., Aasland R., White-Cooper H., Dyson N., Brehm A. Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes. Cell. 119:2004;181-193
29. Kraus W.L., Manning E.T., Kadonaga J.T. Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates. Mol. Cell. Biol. 19:1999;8123-8135
30. Lau O.D., Courtney A.D., Vassilev A., Marzilli L.A., Cotter R.J., Nakatani Y., Cole P.A. p300/CBP-associated factor histone acetyltransferase processing of a peptide substrate. Kinetic analysis of the catalytic mechanism. J. Biol. Chem. 275:2000;21953-21959
31. Li S., Labrecque S., Gauzzi M.C., Cuddihy A.R., Wong A.H.T., Pellegrini S., Matlashewski G.J., Koromilas A.E. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α Oncogene. 18:1999;5727-5737
32. Liu Y., Chen J.J., Gao Q., Dalal S., Hong Y., Mansur C.P., Band V., Androphy E.J. Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J. Virol. 73:1999;7297-7307
33. Lomvardas S., Thanos D. Modifying gene expression programs by altering core promoter chromatin architecture. Cell. 110:2002;261-271
34. Mal A., Sturniolo M., Schiltz R.L., Ghosh M.K., Harter M.L. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD. inhibition of the myogenic program EMBO J. 20:2001;1739-1753
35. Mantovani F., Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene. 20:2001;7874-7887
36. Martinez-Campa C., Politis P., Moreau J.-L., Kent N., Goodall J., Mellor J., Goding C.R. Precise nucleosome positioning and the TATA box dictate requirements for the histone H4 tail and the bromodomain factor Bdf1. Mol. Cell. 15:2004;69-81
37. McMurray H.R., McCance D.J. Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7. J. Virol. 78:2004;5698-5706
38. Mietz J.A., Unger T., Huibregtse J.M., Howley P.M. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11:1992;5013-5020
39. Näär A.M., Beaurang P.A., Robinson K.M., Oliner J.D., Avizonis D., Scheek S., Zwicker J., Kadonaga J.T., Tjian R. Chromatin, TAFs, and a novel multiprotein coactivator are required for synergistic activation by Sp1 and SREBP-1a in vitro. Genes Dev. 12:1998;3020-3031
40. Owen-Hughes T., Utley R.T., Steger D.J., West J.M., John S., Côté J., Havas K.M., Workman J.L. Analysis of nucleosome disruption by ATP-driven chromatin remodeling complexes. Methods Mol. Biol. 119:1999;319-331
41. Patel D., Huang S.-M., Baglia L.A., McCance D.J. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 18:1999;5061-5072
42. Pipas J.M., Levine A.J. Role of T antigen interactions with p53 in tumorigenesis. Semin. Cancer Biol. 11:2001;23-30
43. Ronco L.V., Karpova A.Y., Vidal M., Howley P.M. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:1998;2061-2072
44. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:1993;495-505
45. Schiltz R.L., Mizzen C.A., Vassilev A., Cook R.G., Allis C.D., Nakatani Y. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J. Biol. Chem. 274:1999;1189-1192
46. Shimizu M., Li W., Shindo H., Mitchell A.P. Transcriptional repression at a distance through exclusion of activator binding in vivo. Proc. Natl. Acad. Sci. USA. 94:1997;790-795
47. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell. 103:2000;843-852
48. Sherr C.J. Principles of tumor suppression. Cell. 116:2004;235-246
49. Shieh S.-Y., Ikeda M., Taya Y., Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell. 91:1997;325-334
50. WAF1/CIP1 induction of p300 transactivation. Mol. Cell. Biol. 20:2000;2676-2686
51. WAF1/CIP1. Nature. 389:1997;187-190
52. Sterner D.E., Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64:2000;435-459
53. Talis A.L., Huibregtse J.M., Howley P.M. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J. Biol. Chem. 273:1998;6439-6445
54. Verma S., Ismail A., Gao X., Fu G., Li X., O'Malley B.W., Nawaz Z. The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for steroid hormone receptors. Mol. Cell. Biol. 24:2004;8716-8726
55. Wang T., Kobayashi T., Takimoto R., Denes A.E., Snyder E.L., el-Deiry W.S., Brachmann R.K. hADA3 is required for p53 activity. EMBO J. 20:2001;6404-6413
56. Wu S.-Y., Chiang C.-M. Properties of PC4 and RNA polymerase II complex in directing activated and basal transcription in vitro. J. Biol. Chem. 273:1998;12492-12498
57. Wu S.-Y., Chiang C.-M. TATA-binding protein-associated factors enhance the recruitment of RNA polymerase II by transcriptional activators. J. Biol. Chem. 276:2001;34235-34243
58. II-independent activation mediated by human TBP in the presence of the positive cofactor PC4. EMBO J. 17:1998;4478-4490
59. Wu S.-Y., Thomas M.C., Hou S.Y., Likhite V., Chiang C.-M. Isolation of mouse TFIID and functional characterization of TBP and TFIID in mediating estrogen receptor and chromatin transcription. J. Biol. Chem. 274:1999;23480-23490
60. Wu S.-Y., Zhou T., Chiang C.-M. Human mediator enhances activator-facilitated recruitment of RNA polymerase II and promoter recognition by TATA-binding protein (TBP) independently of TBP-associated factors. Mol. Cell. Biol. 23:2003;6229-6242
61. Yamaguchi Y., Inukai N., Narita T., Wada T., Handa H. Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA. Mol. Cell. Biol. 22:2002;2918-2927
62. II55 core promoter activity. Nucleic Acids Res. 30:2002;4145-4157